Evidence map›Paper›PMID 40507253›Full record

ArticleCancers2025

ADAM32 Oncogene in Hepatoblastoma Is Regulated by IGF2BP2.

Takahiro Fukazawa, Keiji Tanimoto, Masato Kojima, Masami Kanawa, Nobuyuki Hirohashi, Eiso Hiyama

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takahiro FukazawaNatural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan.
Keiji TanimotoDepartment of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0003-4912-4197
Masato KojimaNatural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan.
Masami KanawaNatural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0003-2289-9320
Nobuyuki HirohashiDepartment of Radiation Disaster Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0001-6237-214X
Eiso HiyamaNatural Science Center for Basic Research and Development, Hiroshima University, Hiroshima 734-8553, Japan.ORCID 0000-0001-9179-5037

Funding

Japan Agency for Medical Research and Development 19ck0106332h0003Japan Society for the Promotion of Science JP17K16265, JP20K17554
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADAM32hepatoblastomaHIFhypoxiaIGF2BP2

Identifiers

PMID40507253
PMCPMC12153665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.